Date
Contents
2019
Company Name Changed to ¡®Bioinnotis¡¯
2018
Complex Minoxyl has been technology transfer to HDP.
2018
Complex Minoxyl has been approved in KFDA
2018
Pemirosal tablet 5mg, 10mg has been approved in KEDA
2017
Pemirosal tablet 5mg, 10mg has been technology transfer to HDP.
2017
Lacopat tablet 50mg, 100mg has been approved in KFDA.
2017
Dimantin tablet 5mg, 10mg has been technology transfer to HDP.
2017
Dimantin tablet 5mg, 10mg has been approved in KFDA
2016
Lacopat tablet 50mg, 100mg has been technology transfer to HDP.
2015
DistricAth® has been approved in Thailand
2015
Minoxyl solution 5% has been approved in Myanmar
2014
Mooplas-F solution has been approved in Mongolia
2014
Minoxyl solution 5% was submitted in Cambodia
2014
Moolpas-F and Bumooly-S have been approved from US FDA
2014
Mirtapin (Mirtazapine) tablet 15mg has been approved in Hong Kong
2014
Mirap (Pramipexole) SR tablet 0.75mg was submitted in TFDA
2014
Olapin (Olanzapine) tablet 5mg and 10mg have been approved in Hong Kong
2014
Varosc (Amlodipine) tablet has been approved in Cambodia
2014
Signed license-out and supply agreement of Surfolase (Acebrophyline) capsule with Novotek, China
2013
Choline alfoscerate SR has been selected as one of projects supported by Ministry of Health and Welfare
2013
Signed an exporting contract of Varosc tablet with Cambodia
2013
Signed an exporting contract of Minoxyl solution 5% with Myanmar
2013
Signed an exporting contract with Hong Kong (Olanzapine, Mirtazapine)
2013
Registered of patent for Choline Alfoscerate SR and Alfoscerate IR
2013
Registered of patent for Ibandronate
2012
Signed an exporting contract with Yemen (6 products including Drovon tablet)
2012
Signed a technology transfer agreement of Pramipexole SR with ¡°AET¡±
2012
Signed a technology transfer agreement of Ibandronate with 15 domestic companies
2012
Signed a technology transfer agreement of Levetiracetam with 3 domestic companies
2012
Moolpas-F solution is approved in Hong Kong
2011
Signed a technology transfer agreement Tamirin SR (Galantamine SR) with CLOSTER PHARMA S.A for the territory in middle & southern America & Spain, Portugal
2011
Minoxyl(minoxidil) solution 5%, Varosc (amlodipine) tablet are approved in Vietnam
2011
Signed a technology transfer agreement of Olanzapine with 2 domestic companies
2011
Signed a technology transfer agreement of Pitavastatin with 11 domestic companies
2011
Established Global Business Division in charge of entire global business from registration to export on behalf of Hyundai Pharm.
2010
Signed a technology transfer agreement of Adefovir with 6 domestic companies
2010
Signed a technology transfer agreement of Lamivudine with 2 domestic companies
2010
Signed a technology transfer agreement of Telmisartan with Kolmar
2010
Signed a technology transfer agreement of Olmesartan with Kolon
2009
Founded Biopharmartis.